Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Diagnostic Imaging Market

  • MAR2979139
  • 189 Pages
  • July 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
The Global Diagnostic Imaging Market is valued at USD XX Billion in 2016 and is poised to reach USD XX Billion by 2022 growing at a CAGR of XX% during the forecast period. Medical imaging is a prerequisite in most of the treatments as a means to examine patients and establish their exact medical condition. With the increasing awareness on preventive care, people undergo medical check-ups more often than earlier which has resulted in such imaging techniques gaining significance. The diagnostic imaging advancements have made it possible for doctors to monitor, diagnose, screen, and ensure effective medical intervention.

Market Dynamics

The major growth drivers of the Global Diagnostic Imaging Market are rising geriatric population, advancements in imaging technologies, wide application of such devices, extensive funding and grants from government and public-private organisations, growing number of imaging centres and incidence of various chronic diseases due to a sedentary lifestyle.

However, parallel factors like high cost of imaging system & procedures, side-effects of radiation during imaging and poor insurance coverage especially in developing countries are restraining the growth of the market.

Rising incidence of chronic illnessescoupled with increased acceptance to and preventive healthcare and improved technological advancements in imagingact as opportunity drivers for the market players.

Market Segmentation

The market is segmented on various parameters. The first broad segmentation is based on the type into X-Rays, Nuclear Imaging,Ultrasound, MRI, Computed Tomography, Photoacoustic Imaging, Thermography, Tactile Imaging, Elastography, Functional near-infrared spectroscopy, Echocardiography. Each of these broad types is further classified into sub-segments on the basis ofportability, structure, technology and resolution.X-ray and ultrasound systems market is classified on the basis of technology and portability, CT scanners market by slice type and MRI systems on the basis of architecture and field strength. The nuclear imaging systems market is categorized into SPECT(Single-photon Emission Computed Tomography) and Hybrid PET(Photon Emission Tomography) systems which are further divided into standalone and hybrid models.

The second market segmentation is based on application, intoobstetrics/gynaecology (OB/GYN) health, orthopaedics and musculoskeletal, neurology and spine, cardiovascular and thoracic, general imaging, breast health and others.

The third segmentation is based on the end user, intohospitals, diagnostic imaging centres and other end users (including pharmaceutical & biotechnology companies, academic & research centres, sports academies, and CROs).

Regional/Geographic Analysis

In terms of geography, the Global Diagnostic Imaging Marketis divided into North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific Excluding Japan (APEJ), Japan, and Middle East & Africa (MEA). North America remains the biggest market due to rising geriatric population and chronic illnesses. On the other hand, APEJ with countries like India and China is the fastest growing market for diagnostic imaging market due to increased government funding, improvements in health infrastructure and acceptance of and familiarity to new imaging procedures.

Key Players

Some of the major players in the market are GE Healthcare, Hitachi Medical Corporation, Hologic, Inc, Philips Healthcare Shimadzu Corporation and Siemens Healthcare. GE Healthcare dominates in term of the market share of the industry.

The report contains comprehensive analysis on:

--> Global Diagnostic Imaging MarketSegments

--> Global Diagnostic Imaging MarketDrivers, Restraints and Opportunities

--> Global Diagnostic Imaging MarketSize & Forecast 2016 to 2022

--> Supply & Demand Value Chain

--> Global Diagnostic Imaging MarketCurrent Trends

--> Competition & Major Companies

--> Technology and R&D Status

--> Porters Five Force Analysis

--> Strategic and Critical Success Factor Analysis of Key Players

Regional analysis for Global Diagnostic Imaging Marketincludes

--> North America

>> US and Canada

--> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

--> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

--> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

--> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

--> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.

Report Highlights::

--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

--> Consumer and Pricing Analysis

--> Market dynamics of the industry

--> In-depth Market Segmentation

--> Historical and Projected Market Sizing in terms of volume and value

--> Recent market trends and Impact Factors

--> R&D Status and Technology Overview

--> Extensive Industry Structure Coverage

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390